Experimental ‘enhancer’ drug may boost conventional therapies for deadly pediatric brain cancers

Laboratory studies suggest that an experimental drug already in early clinical trials for a variety of adult cancers might enhance radiation and chemotherapy for two childhood brain cancers that currently are virtually always fatal.